News related to Rituxan (Rituximab) and/or conditions it is approved for
Patients with frequently relapsing kidney disease benefit from immune drug
Source: Arthritis / Rheumatology News From Medical News Today [2014.02.03]
In patients with a frequently-relapsing form of kidney disease, relapses decreased approximately five-fold for at least one year after patients took a single dose of rituximab, an antibody that targets the immune system and is often used to treat immune disorders such as lymphoma and arthritis.
Source: MedicineNet Biological Therapy Specialty [2011.09.08]
Title: Non-Hodgkin's Lymphoma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 9/8/2011 12:00:00 AM
Scientists explore promising new option for first line of attack in lymphoma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.02.26]
A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma.Follicular lymphoma is a type of non-Hodgkin's lymphoma, a blood cancer, that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage.